A Phase 2 Study of Dexlansoprazole Delayed-Release Capsules to Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Pediatric Subjects Aged 1 to 11 Years

Condition:   Gastroesophageal RefluxIntervention:   Drug: DexlansoprazoleSponsor:   TakedaNot yet recruiting - verified November 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials